Literature DB >> 29171167

A clinical study comparing digital radiography and near-infrared transillumination in caries detection.

Stephen C Berg1, Jonathan Miles Stahl2, Wen Lien3, Casey M Slack4, Kraig S Vandewalle4.   

Abstract

OBJECTIVE: The purpose of this study was to compare the effectiveness of detecting proximal carious lesions utilizing a new near-infrared transillumination (NIRTI) system (CariVu, Dexis) to traditional digital bitewing radiography (BWXR).
MATERIALS AND METHODS: Thirty patients received four posterior BWXRs and all premolars and molars were individually imaged with the NIRTI device. Sixty-seven proximal carious lesions were classified based on their depth into enamel or dentin for both BWXR and NIRTI images.
RESULTS: The caries depth classification between the two systems were strongly correlated (rs  = 0.66; Spearman range: 0.60-0.79 = strong) and significant (P < .001) with a median score of 3 for NIRTI and 2 for BWXR.
CONCLUSIONS: The new NIRTI system (CariVu) may serve as an adjunct to BWXR in the diagnosis of proximal caries. CLINICAL SIGNIFICANCE: The NIRTI system could serve as an adjunct diagnostic system that could be used in high-caries risk programs where patients are closely monitored with regimented follow-up appointments. NIRTI could also be beneficial with pregnant or pediatric patients, and in situations where radiography may not be available such as remote humanitarian missions.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  adjunctive diagnosis; caries detection; digital radiography; near-infrared transillumination

Mesh:

Year:  2017        PMID: 29171167     DOI: 10.1111/jerd.12346

Source DB:  PubMed          Journal:  J Esthet Restor Dent        ISSN: 1496-4155            Impact factor:   2.843


  1 in total

1.  In vitro validation of near-infrared transillumination at 780 nm for the detection of caries on proximal surfaces.

Authors:  Alexander Lederer; Karl-Heinz Kunzelmann; Katrin Heck; Reinhard Hickel; Friederike Litzenburger
Journal:  Clin Oral Investig       Date:  2019-01-28       Impact factor: 3.573

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.